The US Supreme Court has preserved access to a commonly used abortion pill, ruling the drug can remain available while a legal case continues.
In a split decision, it also rejected restrictions on mifepristone implemented by a lower court, essentially maintaining the status quo.The future of the drug was first put in question after a Texas judge sought to invalidate its long-standing approval.
The case could have wide-ranging implications for abortion access.It comes after the country’s top court – which has a 6-3 conservative supermajority – overturned Roe v Wade in June last year, ending the nationwide guarantee to abortion and giving states the power to ban the procedure.
While Friday’s ruling returns the mifepristone case to the 5th Circuit Court of Appeals, it is likely that the case will come before the Supreme Court once again, setting up the most significant ruling for reproductive rights since Roe was overturned.Mifepristone is part of a two-drug regimen that now accounts for more than half of abortions in the country.
It has been used by more than five million women in the US to end their pregnancies.It was first approved by the US Food and Drug Administration (FDA) more than 20 years ago after four years of review.
The FDA also placed mifepristone in a category of 60 drugs that are regulated under a system of extra restrictions and regular evaluations.Its safety and effectiveness is supported by mainstream medical organisations including the American College of Obstetrics and Gynaecologists (ACOG) and the World Health Organization (WHO).But earlier this month, Texas court Judge Matthew Kacsmaryk ruled to suspend the FDA approval of mifepristone, saying the FDA had violated federal rules that allowed for the accelerated approval of some drugs, and had erred in its scientific assessment of the drug.Mr Kacsmaryk’s preliminary decision came after a group of anti-abortion health professionals launched a case challenging the safety of mifepristone.
US President Joe Biden’s administration appealed, and a divided appeals court said mifepristone could remain available, but with certain restrictions, while the appeal was under way.Among the restrictions imposed by the 5th Circuit Court of Appeals were a limit on sending the pills by mail, effectively requiring in-person visits.
- I Have Decided To Stop Singing In Twi, I Will Only Sing In English – Diana Asamoah Advises Her Fans
- No Power Can End His Life’ – Prophet Armstrong Declares Over Funny Face Following Chilling Prophecy
- Apologise to Ghanaians and appoint more than 60 ministers – Afenyo-Markin to Mahama
- Take your destiny into your hands” – Kudjoe Fianoo to Ghanaian Clubs
- Europa League: Man United’s Bruno Fernandes scores late winner against Rangers
These restrictions have now been overturned by the Supreme Court.Two of the court’s conservative members, Justice Clarence Thomas and Justice Samuel Alito, dissented publicly to Friday’s decision, which came hours before a midnight deadline.
Justice Thomas provided no reasons for his dissent, while Justice Alito wrote that the Supreme Court has been criticised in the past for issuing emergency orders, called the “shadow docket” by critics.